Universal Beteiligungs und Servicegesellschaft mbH lifted its stake in Globe Life Inc. (NYSE:GL - Free Report) by 41.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 77,780 shares of the company's stock after buying an additional 22,721 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH owned approximately 0.10% of Globe Life worth $10,919,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Transcend Capital Advisors LLC boosted its holdings in Globe Life by 3.9% during the 4th quarter. Transcend Capital Advisors LLC now owns 2,265 shares of the company's stock valued at $317,000 after acquiring an additional 84 shares during the period. Natural Investments LLC increased its stake in Globe Life by 2.6% in the 4th quarter. Natural Investments LLC now owns 3,452 shares of the company's stock worth $482,000 after purchasing an additional 87 shares during the period. CX Institutional lifted its position in Globe Life by 5.6% in the third quarter. CX Institutional now owns 1,805 shares of the company's stock valued at $258,000 after purchasing an additional 96 shares during the last quarter. Laird Norton Wetherby Wealth Management LLC lifted its position in Globe Life by 2.2% in the third quarter. Laird Norton Wetherby Wealth Management LLC now owns 4,518 shares of the company's stock valued at $646,000 after purchasing an additional 99 shares during the last quarter. Finally, KLP Kapitalforvaltning AS boosted its stake in shares of Globe Life by 0.5% during the third quarter. KLP Kapitalforvaltning AS now owns 22,000 shares of the company's stock valued at $3,145,000 after purchasing an additional 100 shares during the period. Institutional investors own 81.61% of the company's stock.
Insiders Place Their Bets
In other news, CMO Jennifer Allison Haworth sold 10,000 shares of the company's stock in a transaction dated Thursday, February 12th. The shares were sold at an average price of $143.14, for a total value of $1,431,400.00. Following the sale, the chief marketing officer directly owned 17,479 shares of the company's stock, valued at $2,501,944.06. This represents a 36.39% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Mark A. Blinn sold 1,750 shares of the stock in a transaction dated Friday, February 6th. The stock was sold at an average price of $147.91, for a total transaction of $258,842.50. Following the completion of the transaction, the director owned 3,372 shares of the company's stock, valued at approximately $498,752.52. The trade was a 34.17% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 82,807 shares of company stock valued at $12,041,286 in the last 90 days. Corporate insiders own 2.11% of the company's stock.
Analysts Set New Price Targets
Several research analysts recently commented on GL shares. JPMorgan Chase & Co. lifted their target price on shares of Globe Life from $180.00 to $181.00 and gave the stock an "overweight" rating in a research note on Thursday, February 5th. Texas Capital raised shares of Globe Life to a "strong-buy" rating in a report on Wednesday, March 18th. Weiss Ratings upgraded shares of Globe Life from a "hold (c+)" rating to a "buy (b)" rating in a research report on Monday, April 13th. Evercore set a $157.00 target price on shares of Globe Life in a report on Wednesday, February 18th. Finally, Truist Financial boosted their price target on Globe Life from $180.00 to $185.00 and gave the company a "buy" rating in a report on Friday. Two equities research analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and two have issued a Hold rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Buy" and an average target price of $172.67.
Check Out Our Latest Research Report on GL
Globe Life Price Performance
Shares of NYSE GL opened at $152.31 on Monday. Globe Life Inc. has a 1 year low of $111.13 and a 1 year high of $155.08. The stock has a market capitalization of $11.95 billion, a P/E ratio of 10.53 and a beta of 0.47. The company's 50-day moving average is $143.66 and its 200 day moving average is $139.57. The company has a debt-to-equity ratio of 0.39, a current ratio of 0.07 and a quick ratio of 0.07.
Globe Life (NYSE:GL - Get Free Report) last issued its quarterly earnings data on Wednesday, April 22nd. The company reported $3.43 EPS for the quarter, missing the consensus estimate of $3.46 by ($0.03). Globe Life had a return on equity of 21.30% and a net margin of 19.38%.The company had revenue of $1.56 billion during the quarter, compared to analysts' expectations of $1.56 billion. During the same quarter last year, the business earned $3.07 earnings per share. The business's quarterly revenue was up 5.3% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. On average, sell-side analysts expect that Globe Life Inc. will post 15.45 earnings per share for the current year.
Globe Life Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, May 1st. Investors of record on Friday, April 3rd will be paid a $0.33 dividend. The ex-dividend date of this dividend is Thursday, April 2nd. This is a positive change from Globe Life's previous quarterly dividend of $0.27. This represents a $1.32 annualized dividend and a yield of 0.9%. Globe Life's payout ratio is currently 9.13%.
Globe Life Profile
(
Free Report)
Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.
The company's product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.
Recommended Stories
Want to see what other hedge funds are holding GL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Globe Life Inc. (NYSE:GL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Globe Life, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Globe Life wasn't on the list.
While Globe Life currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report